These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34794796)

  • 1. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process.
    De Santis GC; Ubiali EMA; Zanelli APRD; Mendrone Junior A; Feitoza A; Kutner JM; Orellana MD; Rizzo SRCP; Covas DT; Langhi Junior DM
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S42-S45. PubMed ID: 34794796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia.
    Seber A; de CastroJunior CG; Kerbauy LN; Hirayama AV; Bonfim C; Fernandes JF; Souza M; Schafell R; Nabhan S; Loggetto SR; Simões BP; Rocha V; de Lima M; Guerino-Cunha RL; Bittencourt H
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S13-S21. PubMed ID: 34794791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VIII: CAR-T cells: preclinical development - Safety and efficacy evaluation.
    Picanço-Castro V; Bonamino MH; Ramos RN; Guerino-Cunha RL; Oliveira TGM; Rego EM
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S54-S63. PubMed ID: 34794798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors.
    Nardo M; Motta TC; Colli LM; Avanzi MP
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S78-S83. PubMed ID: 34794801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special article: compassionate use and clinical trial on CAR-T cells.
    De Santis GC
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S64-S67. PubMed ID: 34794799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards.
    Anthias C; O'Donnell PV; Kiefer DM; Yared J; Norkin M; Anderlini P; Savani BN; Diaz MA; Bitan M; Halter JP; Logan BR; Switzer GE; Pulsipher MA; Confer DL; Shaw BE
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):514-9. PubMed ID: 26597079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
    Warkentin PI;
    Cytotherapy; 2003; 5(4):299-305. PubMed ID: 12944235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control.
    De Santis GC; Langhi Junior DM; Feitoza A; Mendrone Junior A; Kutner JM; Covas DT; Couto SCF; Guerino-Cunha RL; Orellana MD; Rizzo SRCP
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S35-S41. PubMed ID: 34794795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma.
    Alencar AJ; Hirayama AV; Clé DV; Salvino MA; Perini G; Arrais C; Baiocchi O; Palma LC; Colturato I; Vaz J; Chiattone R; de Lima M; Filho JS; Nabhan S; Rocha V; Guerino-Cunha RL; Chiattone CS
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S22-S29. PubMed ID: 34794792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of JACIE accreditation results in the establishment of new indicators that unevenly monitor processes contributing to the delivery of hematopoietic SCT.
    Caunday O; Agulles O; McGrath E; Empereur F; Stoltz JF; Chabannon C
    Bone Marrow Transplant; 2013 Apr; 48(4):604-9. PubMed ID: 23528642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.
    Hungria VT; Crusoe EQ; Quero AA; Sampaio M; Maiolino A; Bernardo WM
    Rev Bras Hematol Hemoter; 2013; 35(3):201-17. PubMed ID: 23904813
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2022. Part I.
    Maiolino A; Crusoé EQ; Martinez GA; Braga WMT; de Farias DLC; Bittencourt RI; Neto JVP; Ribeiro GN; Bernardo WM; Tristão L; Magalhaes RJP; Hungria VTM
    Hematol Transfus Cell Ther; 2022; 44(3):410-418. PubMed ID: 35970751
    [No Abstract]   [Full Text] [Related]  

  • 13. Guidelines on Beta-thalassemia major - regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira - 2016.
    Langhi D; Ubiali EM; Marques JF; Verissimo MA; Loggetto SR; Silvinato A; Bernardo WM
    Rev Bras Hematol Hemoter; 2016; 38(4):341-345. PubMed ID: 27863763
    [No Abstract]   [Full Text] [Related]  

  • 14. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients.
    Clé DV; Hirayama AV; Alencar AJ; Costa LJ; Feliciano JVP; Mattos ER; Cordeiro AC; Salvino MA; Barros GMN; de Lima M; Scheinberg P; Guerino-Cunha RL
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S3-S12. PubMed ID: 34794793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients.
    Maiolino A; Costa LJ; Pasquini M; Crusoe EQ; Vigorito AC; Salvino MA; Seguro FS; Filho JS; Hungria VTM
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S30-S34. PubMed ID: 34794794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil.
    Langhi Junior DM; Maiolino A; Chiattone CS; de Souza CA; Covas DT; Costa FF; Guerino-Cunha RL; Pasquini R
    Hematol Transfus Cell Ther; 2021 Nov; 43 Suppl 2(Suppl 2):S1-S2. PubMed ID: 34326029
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.
    Bittencourt R; Bortolheiro TC; de Lourdes Lopes Ferrari Chauffaille M; Fagundes EM; Pagnano KB; Rego EM; Bernardo WM
    Rev Bras Hematol Hemoter; 2016; 38(1):58-74. PubMed ID: 26969776
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2013.
    Pagnano KB; Rego EM; Rohr S; Chauffaille Mde L; Jacomo RH; Bittencourt R; Firmato AB; Fagundes EM; Melo RA; Bernardo W
    Rev Bras Hematol Hemoter; 2014; 36(1):71-92. PubMed ID: 24624041
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.